ICM+: Pioneering Neuromonitoring Research for over 20 Years

This September marked the 20th anniversary of ICM+, a groundbreaking clinical research software developed by Dr Peter Smielewski and Professor Marek Czosnyka. Over the past two decades, ICM+ has advanced neurological intensive care by providing real-time multimodality monitoring, analysis, and data storage.

Changing the landscape of clinical technology

ICM+ stands out as a pioneering clinical research software solution, offering high-resolution data collection and real-time analysis from multiple bedside monitoring sources. This innovative tool facilitates the collation, integration, user-configurable analysis, and presentation of high-resolution, fluctuating data generated in neurological intensive care environments.

Licensed to hospitals worldwide, ICM+ implements methodologies introduced by the Brain Physics group at the Department of Clinical Neurosciences, University of Cambridge, UK, with over 500 publications on PubMed. Research licenses have been granted to over 200 institutions across 40 countries, resulting in nearly 800 agreements globally.

From idea development to investment, Cambridge Enterprise provide the diverse support needed by researchers, innovators and talented teams tackling the challenges facing the world today.

As the innovation arm of the University of Cambridge, Cambridge Enterprise are responsible for supporting the translation of Cambridge research to create globally-leading economic and social impact.

To find out more about ICM+ and Cambridge Enterprise, please visit: Cambridge Enterprise ICM+

Cambridge Filmworks

Cambridge Film, Content and Video Productions

www.cambridgefilmworks.com